Tarsus Pharmaceuticals, Inc. TARS Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $104.19M-44.0% | $186.2M+61.5% | $115.29M+16.2% | $99.21M-44.4% | $178.35M+83.1% | ||
| $286.54M+22.6% | $233.63M-19.2% | $289.11M+1.6% | $284.5M+22.6% | $232.13M+18.1% | ||
| $100.34M+18.0% | $85.06M+17.1% | $72.62M+24.5% | $58.33M-6.6% | $62.43M+33.5% | ||
| $2.53M-0.2% | $2.53M0.0% | $2.53M0.0% | $2.53M0.0% | $2.53M0.0% | ||
| $537.23M+2.8% | $522.78M+4.2% | $501.7M+5.7% | $474.43M-1.3% | $480.77M+34.8% | ||
| $17.67M+51.5% | $11.67M+103% | $5.75M+80.6% | $3.18M+14.2% | $2.79M+20.4% | ||
| $7.13M-3.3% | $7.37M-3.2% | $7.61M-3.1% | $7.85M-3.0% | $8.09M-2.9% | ||
| $581.14M+3.4% | $562.16M+5.2% | $534.56M+8.0% | $494.99M-1.1% | $500.75M+32.8% | ||
| $24.13M+47.3% | $16.39M-59.7% | $40.64M+44.8% | $28.08M-1.1% | $28.38M+201% | ||
| $143.51M+5.8% | $135.7M+15.9% | $117.05M+29.7% | $90.25M+4.6% | $86.31M+7.1% | ||
| $72.6M+0.2% | $72.44M+0.2% | $72.28M+0.2% | $72.13M+0.2% | $71.98M+0.2% | ||
| $232.18M+6.1% | $218.73M+9.7% | $199.48M+22.8% | $162.38M+2.6% | $158.29M+3.8% | ||
| 200M0.0% | 200M0.0% | 200M0.0% | 200M0.0% | 200M0.0% | ||
| -$433.6M-1.6% | -$426.63M-2.0% | -$418.26M-3.1% | -$405.67M-5.3% | -$385.33M-7.0% | ||
| $348.95M+1.6% | $343.43M+2.5% | $335.08M+0.7% | $332.61M-2.9% | $342.46M+52.5% | ||
| $581.14M+3.4% | $562.16M+5.2% | $534.56M+8.0% | $494.99M-1.1% | $500.75M+32.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Tarsus Pharmaceuticals, Inc.'s total assets?
- Tarsus Pharmaceuticals, Inc. (TARS) holds $581.1M in total assets, up 16.1% year over year.
- How much debt does Tarsus Pharmaceuticals, Inc. have?
- Tarsus Pharmaceuticals, Inc. carries $88.7M in total debt against $349.0M of shareholders' equity, a debt-to-equity ratio of 0.25.
- How much cash does Tarsus Pharmaceuticals, Inc. have?
- Tarsus Pharmaceuticals, Inc. holds $104.2M in cash and equivalents.
- Can Tarsus Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 3.74 — current assets exceed current liabilities.
- Where does Tarsus Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Tarsus Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
